25 results for “sarcopenia”. Showing 25 of 39,449.
Frontiers in sarcopenia: Advancements in diagnostics, molecular mechanisms, and therapeutic strategies.
sarcopenia. Proceeding further, we provide a deep-dive into sarcopenia
Clinical, Immunological, and Vesicular Markers in Sarcopenia and Presarcopenia.
Sarcopenia and Presarcopenia. Shuliko LM(1), Svarovsky DA(1)(2), Spirina
Uncovering polygenic and local genetic overlap between sarcopenia and Alzheimer's disease.
sarcopenia-related traits. Multiple AD GWAS datasets and the sarcopenia
Novel metabolic and lipidomic biomarkers of sarcopenia.
sarcopenia is complex and multifactorial and has not been fully
Loss of SELENOW aggravates muscle loss with regulation of protein synthesis and the ubiquitin-proteasome system.
Sarcopenia is characterized by accelerated muscle mass and function loss
Sarcopenia in daily practice: assessment and management.
Sarcopenia is increasingly recognized as a correlate of ageing and is associated
Emerging Targets and Treatments for Sarcopenia: A Narrative Review.
Sarcopenia is characterized by the progressive loss of skeletal muscle
Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials.
Sarcopenia, the age-related loss of muscle mass and function
SIRT1 signaling pathways in sarcopenia: Novel mechanisms and potential therapeutic targets.
Sarcopenia is an aging-related skeletal disease characterized by decreased
Diabetic sarcopenia: metabolic and molecular appraisal.
sarcopenia), in contrast to the normal histological, physiological, and molecular
Sarcopenia and Cognitive Decline in Older Adults: Targeting the Muscle-Brain Axis.
sarcopenia, and cognitive decline. Mitochondrial dysfunction, inflammation, metabolic alterations, declines
Inhibition of CILP2 Improves Glucose Metabolism and Mitochondrial Dysfunction in Sarcopenia via the Wnt Signalling Pathway.
sarcopenia. Lentiviral vectors were used to induce either silencing or overexpression
Polygonatum sibiricum polysaccharide ameliorates skeletal muscle aging and mitochondrial dysfunction via PI3K/Akt/mTOR signaling pathway.
Sarcopenia is currently a life-threatening disease for the elderly
Short-chain fatty acids enhance muscle mass and function through the activation of mTOR signalling pathways in sarcopenic mice.
Sarcopenia is a prevalent muscle disorder in old people leading
Obestatin controls the ubiquitin-proteasome and autophagy-lysosome systems in glucocorticoid-induced muscle cell atrophy.
Sarcopenia Muscle. 2017 Dec;8(6):974-990. doi: 10.1002/jcsm.12222
Multimodal cell atlas of the ageing human skeletal muscle.
sarcopenia) are common manifestations of frailty and are critical contributors
The muscle-brain axis in type 2 diabetes: Molecular pathways linking sarcopenia and cognitive decline.
sarcopenia and cognitive decline, particularly Alzheimer's disease (AD). This
Wnt/β-catenin signaling pathway as an important mediator in muscle and bone crosstalk: A systematic review.
sarcopenia and osteoporosis. More future studies are required to investigate
Effect of (-)-Epicatechin on Mitochondrial Homeostasis in Skeletal Muscle of Female Obese Rats.
sarcopenia (coexistence of muscle mass loss and dysfunction) are a sedentary
CTRP9 as a myokine mitigates sarcopenia via the LAMP-2A/NLRP3 pathway.
Sarcopenia, a degenerative condition marked by progressive skeletal muscle atrophy
Epigenetic inhibition of class I histone deacetylases by MS-275 attenuates diabetic skeletal muscle atrophy via Akt/ARK5-FoxO and myostatin-Smad signaling.
Sarcopenia is highly prevalent in individuals with diabetes and is associated
Hypothesizing Nutrigenomic-Based Precision Anti-Obesity Treatment and Prophylaxis: Should We Be Targeting Sarcopenia Induced Brain Dysfunction?
Sarcopenia," will present evidence to corroborate the existence of Reward
Irisin: A Multifaceted Hormone Bridging Exercise and Disease Pathophysiology.
sarcopenia, obesity, type 2 diabetes, and neurodegenerative diseases, including Alzheimer
Myostatin as a Biomarker for Diagnosis or Prognosis of Frailty and Sarcopenia: Current Knowledge.
Sarcopenia: Current Knowledge. Arrieta H(1), Rodriguez-Larrad A(2), Irazusta
Systematic review of mitochondrial dysfunction and oxidative stress in aging: A focus on neuromuscular junctions.
sarcopenia. However, the morphological and functional changes in mitochondria and their